(NASDAQ: SNY) Sanofi's forecast annual revenue growth rate of 4.49% is not forecast to beat the US Drug Manufacturers - General industry's average forecast revenue growth rate of 6.55%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.98%.
Sanofi's revenue in 2025 is $50,740,000,000.On average, 5 Wall Street analysts forecast SNY's revenue for 2025 to be $63,870,553,208,507, with the lowest SNY revenue forecast at $60,607,167,030,249, and the highest SNY revenue forecast at $66,916,843,958,461. On average, 5 Wall Street analysts forecast SNY's revenue for 2026 to be $68,396,817,061,956, with the lowest SNY revenue forecast at $63,927,158,790,126, and the highest SNY revenue forecast at $71,646,859,611,789.
In 2027, SNY is forecast to generate $73,155,346,447,589 in revenue, with the lowest revenue forecast at $69,722,277,415,483 and the highest revenue forecast at $76,978,879,553,947.